Catalio Capital Management
Signal active
Investment Firm
Overview
Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies. It was created by George Petrocheilos and Dr. Jacob Vogelstein in 2020.
Highlights
Founded
2016
Industry
Financial Services
Employees
11-50
Investment
72
Lead Investment
22
Exits
15
Stages
Late Stage Venture, Private Equity, Early Stage Venture, Seed
Investor Type
Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Catalio Capital Management, established in 2016 and headquartered in New York, New York, United States, North America., specializes in Late Stage Venture, Private Equity, Early Stage Venture, Seed investments across Health Care, Medical, Medical Device, Financial Services, Finance, FinTech, Business Development, Venture Capital, Service Industry, Asset Management. The organization boasts a portfolio of 71 investments, with an average round size of $97.1M and 15 successful exits. Their recent investments include Imperative Care, Montreux Equity Partners, Bain Capital Life Sciences, Ally Bridge Group, Rock Springs Capital. The highest investment round they participated in was $1085.6B. Among their most notable exits are Imperative Care and Montreux Equity Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Catalio Capital Management has made 72 investments. Their most recent investment was on Jul 25, 2024, when Imperative Care raised $150.0M.
Catalio Capital Management has made 20 diversity investments. Their most recent diversity investment was on Apr 05, 2024, when Protara Therapeutics raised $45.0M.
investments
72
Diversity investments
20
Lead investments
22
Number of exits
15
Investments
72
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 25, 2024 | PinkDx | Biotechnology | 40.0M |
| Jun 12, 2024 | Avava | Health Care | 10.0M |
| Jun 18, 2024 | InSightec | Biotechnology | 150.0M |
| Jul 25, 2024 | Imperative Care | Health Care | 150.0M |
InSightecExits
15
Funding Timeline
Funding rounds
72
Investors
1
Funds
3
Funding Rounds
72
Catalio Capital Management has raised 72 rounds. Their latest funding was raised on Jul 25, 2024 from a Series E - Imperative Care round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 25, 2024 | Series A - PinkDx | - | 40.0M | - |
| Jun 12, 2024 | Venture Round - Avava | - | 10.0M | - |
| Jun 18, 2024 | Private Equity Round - InSightec | - | 150.0M | - |
| Jul 25, 2024 | Series E - Imperative Care | - | 150.0M | - |
Investors
1
Catalio Capital Management is funded by 1 investor(s). Kohlberg Kravis Roberts Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Kohlberg Kravis Roberts | Yes | Private Equity Round - Catalio Capital Management | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.